Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,782 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring epidermal growth factor receptor C797S mutation in Japanese non-small cell lung cancer patients with serial cell-free DNA evaluation using digital droplet PCR.
Ariyasu R, Uchibori K, Sasaki T, Tsukahara M, Kiyotani K, Yoshida R, Ono Y, Kitazono S, Ninomiya H, Ishikawa Y, Mizukami Y, Yanagitani N, Fujita N, Nishio M, Katayama R. Ariyasu R, et al. Among authors: yoshida r. Cancer Sci. 2021 Jun;112(6):2371-2380. doi: 10.1111/cas.14879. Epub 2021 May 2. Cancer Sci. 2021. PMID: 33686722 Free PMC article.
EGFR and KRAS Mutations in Triple-Mutated Lung Cancer.
Yoshida R, Sasaki T, Ohsaki Y. Yoshida R, et al. J Thorac Oncol. 2017 Jul;12(7):e92-e93. doi: 10.1016/j.jtho.2017.02.022. J Thorac Oncol. 2017. PMID: 28629545 Free article. No abstract available.
Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non-small-cell Lung Cancer.
Sakakibara-Konishi J, Kitai H, Ikezawa Y, Hatanaka Y, Sasaki T, Yoshida R, Chiba S, Matsumoto S, Goto K, Mizugaki H, Shinagawa N. Sakakibara-Konishi J, et al. Among authors: yoshida r. Clin Lung Cancer. 2019 Sep;20(5):e555-e559. doi: 10.1016/j.cllc.2019.06.021. Epub 2019 Jun 26. Clin Lung Cancer. 2019. PMID: 31307938 Free article. No abstract available.
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer.
Okazaki S, Sasaki T, Yasuda S, Abe M, Yoshida N, Yoshida R, Ishibashi K, Minami Y, Okumura S, Chiba S, Takei H, Hayashi R, Nagato T, Kobayashi H, Sugitani A, Ono Y, Mizukami Y, Kitada M, Ohsaki Y. Okazaki S, et al. Among authors: yoshida r, yoshida n. Oncol Lett. 2021 May;21(5):420. doi: 10.3892/ol.2021.12681. Epub 2021 Mar 28. Oncol Lett. 2021. PMID: 33841581 Free PMC article.
Case Report: Case series: association between blood concentration and side effects of sotorasib.
Shigaki R, Yoshida R, Yagita A, Nagasue K, Naraoka T, Nitanai K, Yanada H, Tenma T, Kida R, Umekage Y, Mori C, Minami Y, Sato H, Iwayama K, Hashino Y, Fukudo M, Sasaki T. Shigaki R, et al. Among authors: yoshida r. Front Oncol. 2023 Nov 16;13:1269991. doi: 10.3389/fonc.2023.1269991. eCollection 2023. Front Oncol. 2023. PMID: 38044989 Free PMC article.
1,782 results